Literature DB >> 31341085

Identification of evolutionary and kinetic drivers of NAD-dependent signaling.

Mathias Bockwoldt1, Dorothée Houry2, Marc Niere3, Toni I Gossmann4,5, Ines Reinartz6,7, Alexander Schug8, Mathias Ziegler3, Ines Heiland9.   

Abstract

Nicotinamide adenine dinucleotide (NAD) provides an important link between metabolism and signal transduction and has emerged as central hub between bioenergetics and all major cellular events. NAD-dependent signaling (e.g., by sirtuins and poly-adenosine diphosphate [ADP] ribose polymerases [PARPs]) consumes considerable amounts of NAD. To maintain physiological functions, NAD consumption and biosynthesis need to be carefully balanced. Using extensive phylogenetic analyses, mathematical modeling of NAD metabolism, and experimental verification, we show that the diversification of NAD-dependent signaling in vertebrates depended on 3 critical evolutionary events: 1) the transition of NAD biosynthesis to exclusive usage of nicotinamide phosphoribosyltransferase (NamPT); 2) the occurrence of nicotinamide N-methyltransferase (NNMT), which diverts nicotinamide (Nam) from recycling into NAD, preventing Nam accumulation and inhibition of NAD-dependent signaling reactions; and 3) structural adaptation of NamPT, providing an unusually high affinity toward Nam, necessary to maintain NAD levels. Our results reveal an unexpected coevolution and kinetic interplay between NNMT and NamPT that enables extensive NAD signaling. This has implications for therapeutic strategies of NAD supplementation and the use of NNMT or NamPT inhibitors in disease treatment.

Entities:  

Keywords:  NAD pathway dynamics and evolution; NAD-dependent signaling and biosynthesis; mathematical modeling; nicotinamide N-methyltransferase (NNMT); nicotinamide phosphoribosyltransferase (NamPT)

Year:  2019        PMID: 31341085      PMCID: PMC6689970          DOI: 10.1073/pnas.1902346116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  73 in total

1.  A mathematical model of the methionine cycle.

Authors:  Michael C Reed; H Frederik Nijhout; Rachel Sparks; Cornelia M Ulrich
Journal:  J Theor Biol       Date:  2004-01-07       Impact factor: 2.691

2.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

3.  Bayes empirical bayes inference of amino acid sites under positive selection.

Authors:  Ziheng Yang; Wendy S W Wong; Rasmus Nielsen
Journal:  Mol Biol Evol       Date:  2005-02-02       Impact factor: 16.240

4.  BAli-Phy: simultaneous Bayesian inference of alignment and phylogeny.

Authors:  Marc A Suchard; Benjamin D Redelings
Journal:  Bioinformatics       Date:  2006-05-05       Impact factor: 6.937

5.  Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.

Authors:  Tao Wang; Xiangbin Zhang; Poonam Bheda; Javier R Revollo; Shin-ichiro Imai; Cynthia Wolberger
Journal:  Nat Struct Mol Biol       Date:  2006-06-18       Impact factor: 15.369

6.  Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.

Authors:  Toshiyuki Araki; Yo Sasaki; Jeffrey Milbrandt
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

7.  FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.

Authors:  Max Hasmann; Isabel Schemainda
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

8.  PAL2NAL: robust conversion of protein sequence alignments into the corresponding codon alignments.

Authors:  Mikita Suyama; David Torrents; Peer Bork
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

Review 9.  Sirtuins: Sir2-related NAD-dependent protein deacetylases.

Authors:  Brian J North; Eric Verdin
Journal:  Genome Biol       Date:  2004-04-28       Impact factor: 13.583

10.  MUSCLE: a multiple sequence alignment method with reduced time and space complexity.

Authors:  Robert C Edgar
Journal:  BMC Bioinformatics       Date:  2004-08-19       Impact factor: 3.169

View more
  24 in total

Review 1.  Location, Location, Location: Compartmentalization of NAD+ Synthesis and Functions in Mammalian Cells.

Authors:  Xiaolu A Cambronne; W Lee Kraus
Journal:  Trends Biochem Sci       Date:  2020-06-25       Impact factor: 13.807

2.  A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus.

Authors:  Ambra A Grolla; Riccardo Miggiano; Daniele Di Marino; Michele Bianchi; Alessandro Gori; Giuseppe Orsomando; Federica Gaudino; Ubaldina Galli; Erika Del Grosso; Francesca Mazzola; Carlo Angeletti; Martina Guarneri; Simone Torretta; Marta Calabrò; Sara Boumya; Xiaorui Fan; Giorgia Colombo; Cristina Travelli; Francesca Rocchio; Eleonora Aronica; James A Wohlschlegel; Silvia Deaglio; Menico Rizzi; Armando A Genazzani; Silvia Garavaglia
Journal:  J Biol Chem       Date:  2020-01-27       Impact factor: 5.157

3.  Evolution of a histone variant involved in compartmental regulation of NAD metabolism.

Authors:  Iva Guberovic; Sarah Hurtado-Bagès; Ciro Rivera-Casas; Gunnar Knobloch; Roberto Malinverni; Vanesa Valero; Michelle M Leger; Jesús García; Jerome Basquin; Marta Gómez de Cedrón; Marta Frigolé-Vivas; Manjinder S Cheema; Ainhoa Pérez; Juan Ausió; Ana Ramírez de Molina; Xavier Salvatella; Iñaki Ruiz-Trillo; Jose M Eirin-Lopez; Andreas G Ladurner; Marcus Buschbeck
Journal:  Nat Struct Mol Biol       Date:  2021-12-09       Impact factor: 15.369

Review 4.  Glioblastoma and Methionine Addiction.

Authors:  Mark L Sowers; Lawrence C Sowers
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

Review 5.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

6.  Interactions among mTORC, AMPK and SIRT: a computational model for cell energy balance and metabolism.

Authors:  Mehrshad Sadria; Anita T Layton
Journal:  Cell Commun Signal       Date:  2021-05-20       Impact factor: 5.712

7.  G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling.

Authors:  Mirja Tamara Prentzell; Ulrike Rehbein; Marti Cadena Sandoval; Ann-Sofie De Meulemeester; Ralf Baumeister; Laura Brohée; Bianca Berdel; Mathias Bockwoldt; Bernadette Carroll; Suvagata Roy Chowdhury; Andreas von Deimling; Constantinos Demetriades; Gianluca Figlia; Mariana Eca Guimaraes de Araujo; Alexander M Heberle; Ines Heiland; Birgit Holzwarth; Lukas A Huber; Jacek Jaworski; Magdalena Kedra; Katharina Kern; Andrii Kopach; Viktor I Korolchuk; Ineke van 't Land-Kuper; Matylda Macias; Mark Nellist; Wilhelm Palm; Stefan Pusch; Jose Miguel Ramos Pittol; Michèle Reil; Anja Reintjes; Friederike Reuter; Julian R Sampson; Chloë Scheldeman; Aleksandra Siekierska; Eduard Stefan; Aurelio A Teleman; Laura E Thomas; Omar Torres-Quesada; Saskia Trump; Hannah D West; Peter de Witte; Sandra Woltering; Teodor E Yordanov; Justyna Zmorzynska; Christiane A Opitz; Kathrin Thedieck
Journal:  Cell       Date:  2021-01-25       Impact factor: 41.582

Review 8.  The 4 D's of Pellagra and Progress.

Authors:  Adrian C Williams; Lisa J Hill
Journal:  Int J Tryptophan Res       Date:  2020-04-16

Review 9.  Advances in NAD-Lowering Agents for Cancer Treatment.

Authors:  Moustafa S Ghanem; Fiammetta Monacelli; Alessio Nencioni
Journal:  Nutrients       Date:  2021-05-14       Impact factor: 5.717

Review 10.  Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer.

Authors:  Renata Novak Kujundžić; Marin Prpić; Nikola Đaković; Nina Dabelić; Marko Tomljanović; Anamarija Mojzeš; Ana Fröbe; Koraljka Gall Trošelj
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.